詳細介紹
品牌 | illumina/美國因美納 | 貨號 | RS-303-1003 |
---|---|---|---|
規格 | 1 kit | 供貨周期 | 兩周 |
主要用途 | 小型全基因組測序 組合試劑 試劑盒 | 應用領域 | 醫療衛生,化工,生物產業,制藥 |
"Illumina/TruSight RNA Pan-Cancer Panel Set B/RS-303-1003/1 Ea
" RS-303-1003 Illumina 產品編號: RS-303-1003美 元 價: $0.00會 員 價: 待定品 牌: Illumina產 地: 美國公 司: Illumina, Inc.產品分類: 其它>其它試劑>芯片公司分類: Clinical Research Products "Product Highlights:
The TruSight RNA Pan-Cancer panel provides a comprehensive analysis of the cancer transcriptome. It offers:
Gene expression information, variant calling, and fusion detection with known and novel gene fusion partners
Optimized, low-input protocol for a wide range of sample types including FFPE
A comprehensive view of cancer pathways
Economical RNA sequencing (RNA-Seq) on a desktop sequencer
Highly Sensitive and Economical Targeted Sequencing
The TruSight RNA Pan-Cancer panel enables the quantitative measurement of gene expression as well as the detection of gene fusions with both known and novel gene fusion partners. The panel accommodates as little as 10 ng of total RNA input (or 20 ng from FFPE samples). The focus on a subset of relevant genes enables RNA-Seq with high sensitivity at 8 samples per run on a desktop sequencer, allowing cost-effective access to NGS for any lab.
Intuitive Cloud-based Data Analysis
Analysis can be performed using the RNA-Seq Alignment BaseSpace App. This intuitive tool performs fusion calling andvariant detection, and provides gene expression profiles, offering a comprehensive solution to all cancer researchers.
TruSight RNA Pan-Cancer Sample Datasets
MiSeq Data
10 ng of human reference RNA (UHR), human reference brain RNA (Brain), cell line RNA (MCF7), and 20 ng of breast tumor FFPE RNA (BT) were prepared using the TruSight RNA Pan-Cancer Panel and sequenced on the MiSeq System. Read mapping and fusion calling were performed using the RNA-Seq Alignment App with STAR aligner on BaseSpace Sequence Hub.
View Project
MiniSeq Data
Human reference RNA (HBRR and UHRR), cell line RNA (MCF7), and breast tumor RNA samples were prepared using the TruSight RNA Pan-Cancer panel, and 8 samples were sequenced on the MiniSeq System at a 2x76bp read length with single indexing. The total yield was 4.2 Gb with 96.8% of bases at or above Q30.
Browse the data in BaseSpace Sequence Hub:
View Run
View Project
Access to this data requires a BaseSpace Sequence Hub login.
Register for BaseSpace Sequence Hub
Specifications:
Assay Time 2.5 days
Hands-On Time 11 hours
Input Quantity 10 ng total RNA,20 - 100 ng FFPE RNA
System Compatibility MiSeq,NextSeq 550,MiSeqDx in Research Mode,MiniSeq,NextSeq 500
Method Targeted RNA Sequencing,Sequencing for Cytogenomics
Variant Class Gene Fusions,Somatic Variants,Novel Transcripts,Transcript Variants
Specialized Sample Types FFPE,Low Input
Technology Sequencing
Species Category Human
Cancer Type Pan-Cancer
"
Illumina公司,致力于新一代測序和芯片技術的生產與開發,提供產品與應用資訊
Illumina公司創立于1998年4月,是遺傳變異和生物學功能分析領域的優秀的產品、技術和服務供應商。通過幫助客戶加快實現生物信息的采集、分析和應用,來改善人類健康。
Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products
Illumina公司基因芯片、二代測序NGS測序儀及相關測序試劑盒等產品
咨詢illumina MiSeq測序試劑盒等產品歡迎您致電 上海易匯生物科技有限公司:1850 1609 238張經理
產品咨詢